Progress in the development of immunotherapy for the treatment of patients with cancer -
SA Rosenberg - Journal of Internal Medicine, 2001 - Blackwell Synergy
... of the melanoma resulted in the breaking of tolerance ... of 104 patients with metastatic
kidney cancer who received ... vitiligo compared with the development of this ...
THE ROLE OF THE FHIT/FRA3B LOCUS IN CANCER -
K Huebner, PN Garrison, LD Barnes, CM Croce - Annual Reviews in Genetics, 1998 - Annual Reviews
... The position of FRA3B is indistinguishable from a familial kidney cancer-associated
3p14.2 translocation break, t(3;8)(p14.2;q24) (10, 24). ...
Tolerance and Cancer: Mechanisms of Tumor Evasion and Strategies for Breaking Tolerance -
MY Mapara, M Sykes - Journal of Clinical Oncology, 2004 - jcojournal.org
... in a new window], Fig 2. Strategies for breaking tolerance. ... a variety of solid tumors
(colon cancer, prostate cancer, melanoma, renal cell carcinoma [RCC ...
Genetic susceptibility to non-polyposis colorectal cancer -
HT Lynch, A de la Chapelle - British Medical Journal, 1999 - jmg.bmj.com
... to keep abreast of these fast breaking events ... ovarian, gastric biliary tract,
uroepithelial, kidney, and central ... The cumulative cancer incidences by the age of ...
NormalFHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell … -
A van den Berg, TG Draaijers, K Kok, T Timmer, AY … - Genes Chromosomes and Cancer, 1997 - doi.wiley.com
... border at about 75 kb?100 kb distal to the break- point of the constitutive
t(3;8) occurring in a family with hereditary renal cell cancer (Cohen et ...
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy -
T Bertani, F Cutillo, C Zoja, M Broggini, G … - Kidney Int, 1986 - nature.com
... which was determined by tubular obstruction and breaking of tubular ... Cancer Res
32:1177?1183, 1972; Giroux L, Smeesters C ... Kidney Int 24:152?159, 1983; Ryan GB ...
Antiangiogenic Therapy: A Universal Chemosensitization Strategy for Cancer? -
RS Kerbel - Science, 2006 - sciencemag.org
... SU11248 or BAY-43-9006 for kidney cancer (Table 1 ... shown success in early-stage breast
cancer as adjuvant ... an antiangiogenic drug during the break periods between ...
Breaking down the barriers to cancer immunotherapy -
E Pur?, JP Allison, RD Schreiber - Nature Immunology, 2005 - nature.com
... Breaking down the barriers to cancer immunotherapy. ... signaling will facilitate the
development of more ... of patients with melanoma and renal cancer treated with ...
Renal cancer: cytogenetic and molecular genetic aspects -
AM Meloni-Ehrig - American Journal of Medical Genetics (Semin. Med. Genet.), 2002 - doi.wiley.com
... Decker et al., 1988], the hereditary renal cancer associated 1 ... adjacent to the
3p14.2 break- point [Boldog ... predispos- ing factors in the development of about 75 ...
Dendritic-cell-based therapeutic vaccination against cancer -
FO Nestle, A Farkas, C Conrad - Current Opinion in Immunology, 2005 - Elsevier
... aspects for the further development of DC ... and J. Allison, Cancer immunotherapy: breaking
the barriers ... responses in metastatic renal cancer patients vaccinated ...
Source: Google Scholar |